De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. - Wikidata - awgldk - TriplyDB

De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.

De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.

http://www.wikidata.org/entity/Q34112037

about

IgG4- related disease: an orphan disease with many faces B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease IgG4-related disease: current challenges and future prospects IgG4-related kidney disease--an update Predictors of disease relapse in IgG4-related disease following rituximab IgG4-related retroperitoneal fibrosis: a newly characterized disease.No evidence to support a role for Helicobacter pylori infection and plasminogen binding protein in autoimmune pancreatitis and IgG4-related disease in a UK cohort.Immunology of IgG4-related disease.IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.Treatment of IgG4-related disease : Current and future approaches.IgG4 related disease of the head and neck Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease.IgG4-related midline destructive lesion.Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies.Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease.Recent advances in understanding and managing IgG4-related disease T Cell Polarization toward TH2/TFH2 and TH17/TFH17 in Patients with IgG4-Related Disease.Neurological Manifestations of IgG4-Related Disease IgG4-associated cholangitis: a comprehensive review.Clinical Manifestations of IgG4-Related Disease in the Pharynx: Case Series and Review of the Literature.IgG4-related disease and the kidney.IgG4-related sclerosing cholangitis: all we need to know.Clinical and pathophysiological issues associated with type 1 autoimmune pancreatitis.IgG4-Related Disease: Retrospective Analysis of One Hundred Sixty-Six Patients.TRP functions in the broncho-pulmonary system.IgG4-related sialadenitis and Sjögren's syndrome.An overview of the diagnosis and management of immunoglobulin G4-related disease.Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.Th1/Th2 Immune Balance and Other T Helper Subsets in IgG4-Related Disease.Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease.Immunoglobulin G4-related disease and its skin manifestations.Follicular helper T cells in the pathogenesis of IgG4-related disease.Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies.Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.The Lung in Dysregulated States of Humoral Immunity.Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.Association of IgG4-Related Disease With History of Malignancy.Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease.

P2860

Q21146649-010DDFAA-4C7D-4285-91C0-C821D001D629 Q24658641-10EFEC23-7CD1-4221-9D4C-2DD3AD09860E Q26765309-79282E19-D3DA-45A7-9F92-5A1979ACE088 Q26866070-4D0FE11B-C22A-4BB7-A99C-603101DA6704 Q27970306-5E880131-C36D-416C-889C-0CF75C48D5CD Q30251491-BA45C53C-A218-4192-BA8A-EB49952D299B Q33764714-15055797-D6D3-468B-B354-D479F5CF5994 Q34471314-587FCD48-4D6C-4A65-AA16-A16C30D9ED93 Q34476970-D202752F-7695-48B0-90D8-63210D277ED0 Q34534496-F9E765AF-1161-4FE5-919C-0464F9906FE1 Q35243992-87F2E2BE-1CD1-4CC1-ADC9-4942D74ECA3B Q35351104-1EE2ED92-FF3E-453E-9486-CA6EA8B95F73 Q36222528-A9282FD6-772B-414A-86E8-D31B17DA4D06 Q37093426-BE23AAFA-1D47-4047-97C6-02DE6F67305F Q37244625-4FE178D0-72C3-4907-B7F6-B6D86C2751F4 Q37635260-BD12D23A-06D0-45D7-A811-0570025AF1D3 Q37638209-DD3211C7-D00B-4677-B81F-2E0F6F4AA9A7 Q37664754-5480C4AE-C8CB-4DA9-A3F1-57A35948C745 Q37695317-A24C27CB-BFB5-43D9-8E78-23EAB9450BBA Q37736043-FE8E0042-A38E-40B9-8A83-B24B2B973FE3 Q38222686-0CF75813-FF90-4A9A-88E8-2F2ACA173639 Q38247515-B17AB9A4-F671-48C9-9EC4-515EE4E88ACA Q38540095-101A98B0-2BAB-4D3A-8BD4-B873FCF6F2FD Q38714087-93233024-5C51-4D84-8E79-79853AD30315 Q38728546-FA4217C1-3F3B-4C0B-88BD-0E57466C7DE4 Q38779583-DA3E7CB6-F560-467E-998C-A47FE37D9997 Q38809502-075ECBFE-ECD8-4DFA-9ED3-667EDFB3B876 Q38869224-01DAFC3B-6CD3-4E70-A8F6-9EA1E9B3DB29 Q38871355-9A90E799-751B-4B36-A8C1-63DEB88B1B26 Q38879044-7F5B149A-1311-45AC-8F06-BD7324677CEF Q38981730-1EC1A2E5-165A-45D6-BD27-9F4E394AE4B3 Q39122674-4735D8C1-85B2-4813-91AF-8050552DC3E6 Q39159826-3A838823-0C8B-4377-B60A-5F75DD2A3F7C Q39275481-FC532D1D-4C4E-437A-80C4-50C5E693D08F Q39346488-B89328AD-0A7F-4EA4-9F0E-C82E36067FAE Q40043818-E492AFE8-80F0-41E3-BDE0-EE277E238B4D Q40045962-8CFA079E-8431-474F-800B-E01DA227FF94 Q40552572-5896D5F2-490E-49F7-883A-621FBECCB1FE Q40713197-31B67428-667A-4314-A29C-DF5A0050E929 Q41036265-715C2459-9898-429E-A60D-E32DEDCC412B

P2860

De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.

http://www.wikidata.org/entity/Q34112037

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@ast

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@en

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@nl

type

label

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@ast

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@en

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@nl

prefLabel

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@ast

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@en

De novo oligoclonal expansions ...... elapsing IgG4-related disease.

@nl

P1433

Q34112037-DE3B7E7A-8E13-4839-9335-D7B7F446642B

P1476

Q34112037-B1A6DE9D-6518-4AE7-B2B3-A39FDD556A7F

P2093

Q34112037-003BBEC9-4E58-47C5-B486-7A465D04E01E

Q34112037-2984C38F-FA8B-49C0-8916-D9FCD9AB09F6

Q34112037-3436128B-5308-4802-9776-DFA114C8E22C

Q34112037-706E1560-283F-48B8-AC04-3DF1973B6C59

Q34112037-97F1C728-D28C-4268-980B-D58CEA9EC16D

Q34112037-ABE5162F-C7DC-4CA9-A8DA-4C5849C2B804

Q34112037-CA8C48CF-D21C-4BDE-98C2-90574AE9957D

P2860

Q34112037-0CCB960C-BB8B-43B0-A5B2-876F00A9025A

Q34112037-19CDB751-57A9-47C4-98E2-1748432A1173

Q34112037-1F684FED-10E2-4B64-A7B7-6C23F5D11668

Q34112037-386FEBA3-823D-4C48-AA74-9B342293AE69

Q34112037-4E22CFBE-18AA-4802-84B4-EAA4B2192B88

Q34112037-57607B88-B305-40EB-9D66-5FD80472D623

Q34112037-5BCF5F31-53DD-4CA5-87D7-93595B106689

Q34112037-6788850E-4307-4100-B814-3F3CEE629740

Q34112037-68F48284-4B1A-4C07-B6D0-7B12CC28E5B0

Q34112037-71D8A908-C4EE-4830-929D-BC72311D5122

P304

Q34112037-6732BA73-6CBC-434A-AE58-D69A68B30959

P31

Q34112037-5AA374B6-229F-4DDA-B4FD-108FDF469F0D

P356

Q34112037-EC163F73-3828-41FE-81B7-D1C730D4AC42

P407

Q34112037-DB22DDA5-404B-4F22-9F8B-1A7DF2692357

P433

Q34112037-3260A2A7-7134-48D3-A25B-785BD5A40528

P478

Q34112037-D0830B85-4E3D-479D-9AF5-521437520BBF

P50

Q34112037-3EF94982-A6EB-474A-98B0-9A8311B989CC

Q34112037-AC66DB69-1FE5-421E-9C4A-3F41B2F1879A

P577

Q34112037-302BF000-1318-499A-B5FD-CC617C062352

P5875

Q34112037-23A12D1C-CEA1-4CE7-8B67-F874C2106A13

P698

Q34112037-48CC853C-1629-4848-9912-2285C3D7F106

P932

Q34112037-BFE0A074-64B9-4903-8A23-EA78C3F2A1DC

P356

J.JACI.2014.03.034

P1433

The Journal of Allergy and Clinical Immunology

P1476

De novo oligoclonal expansions ...... relapsing IgG4-related disease

@en

P2093

Hamid Mattoo

http://www.w3.org/2001/XMLSchema#string

John H Stone

http://www.w3.org/2001/XMLSchema#string

Mollie Carruthers

http://www.w3.org/2001/XMLSchema#string

Shiv Pillai

http://www.w3.org/2001/XMLSchema#string

Vikram Deshpande

http://www.w3.org/2001/XMLSchema#string

Yurie Sekigami

http://www.w3.org/2001/XMLSchema#string

Zachary S Wallace

http://www.w3.org/2001/XMLSchema#string

P2860

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

IgG4-related disease

Development of an IgG4-RD Responder Index.

High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations.

Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.

A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice.

Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis.

CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes.

P304

679-687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2014.03.034

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Emanuel Della Torre

P577

2014-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262226505

http://www.w3.org/2001/XMLSchema#string

P698

24815737

http://www.w3.org/2001/XMLSchema#string

P932

4149918

http://www.w3.org/2001/XMLSchema#string